Cargando…

Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice

AIMS/HYPOTHESIS: Transcription factor 7-like 2 (TCF7L2) is a high mobility group (HMG) box-containing transcription factor and downstream effector of the Wnt signalling pathway. SNPs in the TCF7L2 gene have previously been associated with an increased risk of type 2 diabetes in genome-wide associati...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva Xavier, Gabriela, Mondragon, Angeles, Mourougavelou, Vishnou, Cruciani-Guglielmacci, Céline, Denom, Jessica, Herrera, Pedro Luis, Magnan, Christophe, Rutter, Guy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423960/
https://www.ncbi.nlm.nih.gov/pubmed/28343277
http://dx.doi.org/10.1007/s00125-017-4242-2
_version_ 1783235033307283456
author da Silva Xavier, Gabriela
Mondragon, Angeles
Mourougavelou, Vishnou
Cruciani-Guglielmacci, Céline
Denom, Jessica
Herrera, Pedro Luis
Magnan, Christophe
Rutter, Guy A.
author_facet da Silva Xavier, Gabriela
Mondragon, Angeles
Mourougavelou, Vishnou
Cruciani-Guglielmacci, Céline
Denom, Jessica
Herrera, Pedro Luis
Magnan, Christophe
Rutter, Guy A.
author_sort da Silva Xavier, Gabriela
collection PubMed
description AIMS/HYPOTHESIS: Transcription factor 7-like 2 (TCF7L2) is a high mobility group (HMG) box-containing transcription factor and downstream effector of the Wnt signalling pathway. SNPs in the TCF7L2 gene have previously been associated with an increased risk of type 2 diabetes in genome-wide association studies. In animal studies, loss of Tcf7l2 function is associated with defective islet beta cell function and survival. Here, we explore the role of TCF7L2 in the control of the counter-regulatory response to hypoglycaemia by generating mice with selective deletion of the Tcf7l2 gene in pancreatic alpha cells. METHODS: Alpha cell-selective deletion of Tcf7l2 was achieved by crossing mice with floxed Tcf7l2 alleles to mice bearing a Cre recombinase transgene driven by the preproglucagon promoter (PPGCre), resulting in Tcf7l2AKO mice. Glucose homeostasis and hormone secretion in vivo and in vitro, and islet cell mass were measured using standard techniques. RESULTS: While glucose tolerance was unaffected in Tcf7l2AKO mice, glucose infusion rates were increased (AUC for glucose during the first 60 min period of hyperinsulinaemic–hypoglycaemic clamp test was increased by 1.98 ± 0.26-fold [p < 0.05; n = 6] in Tcf7l2AKO mice vs wild-type mice) and glucagon secretion tended to be lower (plasma glucagon: 0.40 ± 0.03-fold vs wild-type littermate controls [p < 0.01; n = 6]). Tcf7l2AKO mice displayed reduced fasted plasma glucose concentration. Glucagon release at low glucose was impaired in islets isolated from Tcf7l2AKO mice (0.37 ± 0.02-fold vs islets from wild-type littermate control mice [p < 0.01; n = 6). Alpha cell mass was also reduced (72.3 ± 20.3% [p < 0.05; n = 7) in Tcf7l2AKO mice compared with wild-type mice. CONCLUSIONS/INTERPRETATION: The present findings demonstrate an alpha cell-autonomous role for Tcf7l2 in the control of pancreatic glucagon secretion and the maintenance of alpha cell mass and function.
format Online
Article
Text
id pubmed-5423960
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-54239602017-05-25 Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice da Silva Xavier, Gabriela Mondragon, Angeles Mourougavelou, Vishnou Cruciani-Guglielmacci, Céline Denom, Jessica Herrera, Pedro Luis Magnan, Christophe Rutter, Guy A. Diabetologia Article AIMS/HYPOTHESIS: Transcription factor 7-like 2 (TCF7L2) is a high mobility group (HMG) box-containing transcription factor and downstream effector of the Wnt signalling pathway. SNPs in the TCF7L2 gene have previously been associated with an increased risk of type 2 diabetes in genome-wide association studies. In animal studies, loss of Tcf7l2 function is associated with defective islet beta cell function and survival. Here, we explore the role of TCF7L2 in the control of the counter-regulatory response to hypoglycaemia by generating mice with selective deletion of the Tcf7l2 gene in pancreatic alpha cells. METHODS: Alpha cell-selective deletion of Tcf7l2 was achieved by crossing mice with floxed Tcf7l2 alleles to mice bearing a Cre recombinase transgene driven by the preproglucagon promoter (PPGCre), resulting in Tcf7l2AKO mice. Glucose homeostasis and hormone secretion in vivo and in vitro, and islet cell mass were measured using standard techniques. RESULTS: While glucose tolerance was unaffected in Tcf7l2AKO mice, glucose infusion rates were increased (AUC for glucose during the first 60 min period of hyperinsulinaemic–hypoglycaemic clamp test was increased by 1.98 ± 0.26-fold [p < 0.05; n = 6] in Tcf7l2AKO mice vs wild-type mice) and glucagon secretion tended to be lower (plasma glucagon: 0.40 ± 0.03-fold vs wild-type littermate controls [p < 0.01; n = 6]). Tcf7l2AKO mice displayed reduced fasted plasma glucose concentration. Glucagon release at low glucose was impaired in islets isolated from Tcf7l2AKO mice (0.37 ± 0.02-fold vs islets from wild-type littermate control mice [p < 0.01; n = 6). Alpha cell mass was also reduced (72.3 ± 20.3% [p < 0.05; n = 7) in Tcf7l2AKO mice compared with wild-type mice. CONCLUSIONS/INTERPRETATION: The present findings demonstrate an alpha cell-autonomous role for Tcf7l2 in the control of pancreatic glucagon secretion and the maintenance of alpha cell mass and function. Springer Berlin Heidelberg 2017-03-25 2017 /pmc/articles/PMC5423960/ /pubmed/28343277 http://dx.doi.org/10.1007/s00125-017-4242-2 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
da Silva Xavier, Gabriela
Mondragon, Angeles
Mourougavelou, Vishnou
Cruciani-Guglielmacci, Céline
Denom, Jessica
Herrera, Pedro Luis
Magnan, Christophe
Rutter, Guy A.
Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice
title Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice
title_full Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice
title_fullStr Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice
title_full_unstemmed Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice
title_short Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice
title_sort pancreatic alpha cell-selective deletion of tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423960/
https://www.ncbi.nlm.nih.gov/pubmed/28343277
http://dx.doi.org/10.1007/s00125-017-4242-2
work_keys_str_mv AT dasilvaxaviergabriela pancreaticalphacellselectivedeletionoftcf7l2impairsglucagonsecretionandcounterregulatoryresponsestohypoglycaemiainmice
AT mondragonangeles pancreaticalphacellselectivedeletionoftcf7l2impairsglucagonsecretionandcounterregulatoryresponsestohypoglycaemiainmice
AT mourougavelouvishnou pancreaticalphacellselectivedeletionoftcf7l2impairsglucagonsecretionandcounterregulatoryresponsestohypoglycaemiainmice
AT crucianiguglielmacciceline pancreaticalphacellselectivedeletionoftcf7l2impairsglucagonsecretionandcounterregulatoryresponsestohypoglycaemiainmice
AT denomjessica pancreaticalphacellselectivedeletionoftcf7l2impairsglucagonsecretionandcounterregulatoryresponsestohypoglycaemiainmice
AT herrerapedroluis pancreaticalphacellselectivedeletionoftcf7l2impairsglucagonsecretionandcounterregulatoryresponsestohypoglycaemiainmice
AT magnanchristophe pancreaticalphacellselectivedeletionoftcf7l2impairsglucagonsecretionandcounterregulatoryresponsestohypoglycaemiainmice
AT rutterguya pancreaticalphacellselectivedeletionoftcf7l2impairsglucagonsecretionandcounterregulatoryresponsestohypoglycaemiainmice